InterComm International Ltd. - Partner for Medical & Scientific Communication
InterComm International is an established medical and scientific communications agency with extensive experience in life science and clinical development. The team's work centers on medical affairs materials, complemented by strategic communication services and support for clinical development programs.
InterComm International frequently supports clients at critical stages, including the development of a clear scientific selling story, the effective communication of mechanisms of action, and the strategic selection and alignment of indications with regulatory authorities.
In addition, InterComm International has significant experience in addressing clinical trial challenges, particularly in the area of patient recruitment and trial feasibility. This includes strengthening engagement with study centers, improving patient appeal and supporting adaptations to study design, inclusion criteria and trial communication.
As a partner of Excellere, InterComm International complements consulting engagements through the development of scientific narratives, regulatory documentation and coherent communication strategies for scientific audiences, investors and commercial stakeholders. Clients value the analytical depth, reliability and the ability to identify and articulate the story behind the data.
Typical areas of engagement
- Development and execution of medical affairs materials
- Structured communication of mechanisms of action and scientific selling stories
- Development of coherent scientific selling stories
- Strategic communication support during early and critical development phases
- Support in indication selection, prioritization and alignment with regulatory authorities
- Scientific communication concepts to support clinical development programs
- Clinical trial support with a focus on recruitment and feasibility
- Engagement and activation of study centers and medical stakeholders
- Support in optimizing study design, inclusion and exclusion criteria and trial related communication